RAS mutation specific survival in patients with metastatic colorectal cancer treated with trifluridine/tipiracil

被引：0
|
作者：
Grell, Peter
Batko, Stanislav
Pirsthuk, Alina
Borilova, Simona
Polachova, Katerina
Mazuchova, Blanka
Tomasek, Jiri
Fabian, Pavel
Berkovcova, Jitka
Bardelcik, Miroslav
Obermannova, Radka
Buchler, Tomas
Kiss, Igor
机构：
[1] Masaryk Mem Canc Inst, Brno, Czech Republic
[2] Motol Univ Hosp, Prague, Czech Republic
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
613-135-2370-7650-2700; 3282-206-4957-326-5009-5024-5025; 3282-206-4957-326-5009-2386; 10; 2; 38092-25821; 38092-18412; 38092-18849; 8; 4;
D O I：
10.1200/JCO.2024.42.3_suppl.197
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
    Prager, Gerald W.
    Taieb, Julien
    Fakih, Marwan
    Ciardiello, Fortunato
    Van Cutsem, Eric
    Elez, Elena
    Cruz, Felipe M.
    Wyrwicz, Lucjan
    Stroyakovskiy, Daniil
    Papai, Zsuzsanna
    Poureau, Pierre-Guillaume
    Liposits, Gabor
    Cremolini, Chiara
    Bondarenko, Igor
    Modest, Dominik P.
    Benhadji, Karim A.
    Amellal, Nadia
    Leger, Catherine
    Vidot, Loick
    Tabernero, Josep
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (18): : 1657 - 1667
  • [32] Safety and efficacy of trifluridine/tipiracil monotherapy in metastatic colorectal cancer
    Aparicio Rubio, C.
    Monteagudo Santolaya, E.
    Cornejo Uixeda, S.
    Prieto Castello, M.
    Antonino de la Camara, G.
    Quintana Vergara, B.
    Sanchez Alcaraz, A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 373 - 374
  • [33] Trifluridine/tipiracil in metastatic colorectal cancer: a guide to its use
    Lyseng-Williamson K.A.
    Burness C.B.
    Duggan S.T.
    Drugs & Therapy Perspectives, 2017, 33 (3) : 110 - 118
  • [34] The REWRITE Study-REal-WoRld effectIveness of TrifluridinE/tipiracil in Patients with Previously Treated Metastatic Colorectal Cancer
    Marques, D.
    Costa, A. L.
    Mansinho, A.
    Quintela, A.
    Pratas, E.
    Brito-da-Silva, J.
    Cruz, J.
    Felix, J.
    Rodrigues, J.
    Mota, M.
    Teixeira, A. R.
    Damaso, S.
    Pinheiro, S.
    Andreozzi, V.
    Costa, L.
    Barros, A. G.
    CLINICAL ONCOLOGY, 2023, 35 (10) : 665 - 672
  • [35] Codon-specific KRAS mutations predict overall survival benefit of trifluridine/tipiracil in metastatic colorectal cancer.
    van de Haar, Joris
    Ma, Xuhui
    Ooft, Salo N.
    van der Helm, Pim W.
    Hoes, Louisa Rose
    Mainardi, Sara
    Wessels, Lodewyk F. A.
    Voest, Emile E.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [36] Cost-Utility Analysis of Trifluridine/ Tipiracil in treating Metastatic Colorectal Cancer in Previously Treated Patients in Jordan
    Al Rabayah, Abeer
    Sawalha, Razan
    Jaddoua, Saad
    MEDICAL DECISION MAKING, 2024, 44 (02) : NP90 - NP91
  • [37] Cost-effectiveness of Trifluridine/tipiracil for Previously Treated Metastatic Colorectal Cancer in England and Wales
    Bullement, Ash
    Underhill, Stuart
    Fougeray, Ronan
    Hatswell, Anthony James
    CLINICAL COLORECTAL CANCER, 2018, 17 (01) : E143 - E151
  • [38] Real-world use of trifluridine/tipiracil for patients with metastatic colorectal cancer in Canada
    Samawi, H. H.
    Brezden-Masley, C.
    Afzal, A. R.
    Cheung, W. Y.
    Dolley, A.
    CURRENT ONCOLOGY, 2019, 26 (05) : 319 - +
  • [39] Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil plus bevazicumab: Final analysis from a Danish randomised study
    Pfeiffer, P.
    Winther, S.
    Moller, S.
    Poulsen, L.
    Yilmaz, M.
    Qvortrup, C.
    ANNALS OF ONCOLOGY, 2023, 34 : S101 - S101
  • [40] A retrospective study of trifluridine/tipiracil in pretreated metastatic colorectal cancer patients in clinical practice
    Borelli, Beatrice
    Zucchelli, Gemma
    Rossini, Daniele
    Cremolini, Chiara
    Antoniotti, Carlotta
    Moretto, Roberto
    Marmorino, Federica
    Colombo, Camilla
    Vannini, Francesca
    Delliponti, Laura
    Spione, Mario
    Ongaro, Elena
    Masi, Gianluca
    Brunetti, Isa Maura
    Pfanner, Elisabetta
    Salvatore, Lisa
    Falcone, Alfredo
    COLORECTAL CANCER, 2018, 7 (01)
12345